Pine River Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,126,200
Closed -$274M 108
2017
Q2
$274M Sell
1,126,200
-1,434,700
-56% -$337M 7.01% 5
2017
Q1
$612M Buy
2,560,900
+2,300,200
+882% +$536M 12.11% 3
2016
Q4
$54.8M Buy
+260,700
New +$54M 2% 6
2016
Q2
Sell
-34,000
Closed -$31.2M 630
2016
Q1
$31.2M Buy
+34,000
New +$9.73M 0.46% 34

Other funds holding AGN

Pine River Capital Management's AGN Position: Q4 2015 in Review

Pine River Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 4,865 shares — an estimated $1.32M sold.

Pine River Capital Management first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $89.7M in Q3 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Pine River Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Pine River Capital Management sold 4,865 Allergan plc shares in Q4 2015, an estimated $1.32M.
  • Pine River Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 3 quarters.
  • Pine River Capital Management's Allergan plc position peaked at $89.7M in Q3 2014.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.